机译:筛选有效的抗菌肽治疗含有含有含有含有含有Mupirocin的MRSA皮肤感染
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Department of Laboratory Medicine National University Hospital;
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Experimental Therapeutics Centre Agency for Science Technology and Research (A*STAR);
Antimicrobial peptide; Mupirocin-resistant; MRSA; Skin infection; Nasal decolonization;
机译:筛选有效的抗菌肽治疗含有含有含有含有含有Mupirocin的MRSA皮肤感染
机译:从皮肤和软组织感染中分离出的MSSA,MRSA和MRSE临床菌株的表征以及ZnO纳米颗粒的抗菌活性
机译:成人化脓性耐甲氧西林金黄色葡萄球菌(MRSA)皮肤感染的抗菌药物可作为切开引流的辅助手段
机译:化学改性纤维素织物对医院感染细菌的抗菌活性,包括MRSA
机译:多焦点训练的有效性,提高社区收购MRSA皮肤和软组织感染的治疗
机译:针对大肠杆菌O157的有效和特异性抗菌活性:H7和耐甲氧西林金黄色葡萄球菌(MRSA)的G17和G19肽包封在聚乳酸 - 共乙醇酸(PLGA)纳米颗粒中
机译:寻求针对皮肤和软组织感染的新疗法:炔丙基连接的叶酸是MRSA和化脓性链球菌的有效抑制剂